Chinese Pharma Industry Analyzed by Kelly Scientific Publications in New Report Published at MarketPublishers.com10 Mar 2014 • by Natalie Aster
LONDON – At present, China’s pharmaceutical market ranks the 3rd biggest pharma market worldwide, after the USA and Japan. In 2011, the value of the national pharmaceutical market stood at around USD 40 billion. It is anticipated to experience tremendous growth in the years ahead, and by 2020 it is poised to reach USD 200 billion. The country is expected to increase considerably its dominance as an unrivalled leader in the Asian market. China’s pharmaceutical market will likely compete with the US market over the next 6 years. The Chinese pharmaceutical industry has enormous growth prospects and massive potential for investment, and it is predicted to considerably affect the world healthcare universe in the years ahead.
China’s pharmaceutical market is inhabited by numerous high-performing companies, including, among others, Johnson & Johnson Medical, FusoGen Pharmaceuticals, Merck, Abbott, Amoytop Biotech, Novartis, Roche, and SiBiono GeneTech.
Cutting-edge report “Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” worked out by Kelly Scientific Publications provides a close look at the Chinese pharmaceutical industry landscape.
The new research report throws light on the actual market scenario, features the key factors shaping the national market, investigates the prevailing trends and also highlights the country’s business and economic environment. The topical study outlines the major market challenges and opportunities, uncovers a wealth of information showing today’s and historical industry performance. It delves into the competitive climate, and discloses comprehensive profiles of the top market players. Besides, the report looks at the possible ways of the future development of China’s pharmaceutical market.
Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges
Published: March, 2014
Price: US$ 2,750.00
Other Reports by Kelly Scientific Publications Include:
- Personalized Medicine and Companion Diagnostic Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
- Pharmaceutical Market: India A Comprehensive Industry Analysis Q3 2013
- Personalized Medicine and Companion Diagnostic Market Q3 2013- A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment
More new studies by the publisher can be found at Kelly Scientific Publications page.